Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06505447 · ClinicalTrials.gov registry record · NA
PICU-related Sleep and Circadian Dysregulation Pilot Study
A NA study of Critical Illness and Sleep Disturbance, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06505447: Recruiting NA study of Critical Illness and Sleep Disturbance, sponsored by State University of New York at Buffalo.
NCT06505447 is a NA study of Critical Illness and Sleep Disturbance that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 30 participants, below the 3,138-participant average among 91 other Critical Illness trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06505447, a NA study of Critical Illness and Sleep Disturbance, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
A single center pilot trial investigating the feasibility of using actigraphy and salivary melatonin levels to measure the sleep and circadian rhythm of critically ill children aged 3 to 6 years old. This study will also measure the feasibility of providing daytime light exposure as well as restricting all provided nutrition to during daytime hours.
Primary Outcome
The number of days that reliable sleep and CR data are obtained using an actigraph and serial salivary melatonin assays
Conditions Studied
Interventions
- OTHER Daytime light exposure
- OTHER Daytime restricted feeding
Study Locations (1)
New York
- John R. Oishei Children's Hospital - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-12-06 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
What NCT06505447 shows while recruiting
NCT06505447 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 3,138-participant average among 91 other Critical Illness trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which Daytime light exposure is the first listed.
NCT06505447 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06505447 about?
NCT06505447 is a clinical study titled "PICU-related Sleep and Circadian Dysregulation Pilot Study". A single center pilot trial investigating the feasibility of using actigraphy and salivary melatonin levels to measure the sleep and circadian rhythm of critically ill children aged 3 to 6 years old. This study will also measure the feasibility of providing daytime light exposure as well as restrict...
What is the current status of trial NCT06505447?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-12-06. Estimated completion is 2027-01-01.
What conditions does trial NCT06505447 study?
This clinical trial studies the following conditions: Critical Illness, Sleep Disturbance, Children, Only, Circadian Dysrhythmia.
What interventions are being tested in trial NCT06505447?
The interventions under investigation include: Daytime light exposure (OTHER), Daytime restricted feeding (OTHER).
Who is sponsoring clinical trial NCT06505447?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06505447 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06505447's enrollment target sits among peer trials
30 86th of 91 higher than 6 of 91 other Critical Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Improving Needs Among Older Adults
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
12-hour Time Limited Feeding in Critical Care
RECRUITING · NA
-
PUSH-IT Continuing Enteral Feeds for Tracheostomy
RECRUITING · NA
-
Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI